4//SEC Filing
Collins James J. 4
Accession 0001213900-23-041168
CIK 0001847416other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:05 PM ET
Size
5.8 KB
Accession
0001213900-23-041168
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Disposition to Issuer
Class B ordinary shares
2023-05-17−40,000→ 0 total→ Class A ordinary shares (40,000 underlying)
Footnotes (1)
- [F1]On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the "Articles") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023.
Documents
Issuer
Orion Biotech Opportunities Corp.
CIK 0001847416
Entity typeother
Related Parties
1- filerCIK 0001779269
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:05 PM ET
- Size
- 5.8 KB